CAS 154235-83-3: 1-(Quinoxalin-6-ylcarbonyl)piperidine
Formula:C14H15N3O
InChI:InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2
InChI key:InChIKey=ANDGGVOPIJEHOF-UHFFFAOYSA-N
SMILES:C(=O)(C1=CC2=C(C=C1)N=CC=N2)N3CCCCC3
Synonyms:- 1-(Quinoxalin-6-Ylcarbonyl)Piperidine
- 1-Piperidinyl-6-quinoxalinylmethanone
- 6-(Piperidin-1-ylcarbonyl)quinoxaline
- ABT-224,piperidine, 1-(6-quinoxalinylcarbonyl)-
- Bdp 12
- Cx 516
- Methanone, 1-piperidinyl-6-quinoxalinyl-
- Piperidin-1-Yl(Quinoxalin-6-Yl)Methanone
- Piperidin-1-yl-quinoxalin-6-ylmethanone
- Piperidine, 1-(6-quinoxalinylcarbonyl)-
Sort by
Found 6 products.
Piperidin-1-yl(quinoxalin-6-yl)methanone
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:241.29400634765625CX516
CAS:CX516 (Ampalex), an ampakine and nootropic, acts as an AMPA receptor positive allosteric modulator as a therapy for Alzheimer's disease, schizophrenia and MCI.Formula:C14H15N3OPurity:99.29% - ≥95%Color and Shape:Tan SolidMolecular weight:241.29Piperidin-1-yl(Quinoxalin-6-yl)Methanone
CAS:Piperidin-1-yl(Quinoxalin-6-yl)MethanonePurity:97%Molecular weight:241.29g/molAmpalex
CAS:Controlled ProductApplications Ampalex is a AMPA modulator that may exhibit therapeutic properties for treating Alzheimer's disease, schizophrenia, and mild cognitive impairment (MCI) (1,2,3,4). References (1) Morris, H., et al.: Nature, 328, 811 (1987)(2) Addington, D., et al.: Schizophr. Res., 3, 247 (1990) (3) Arai, A., et al.: Neuroscience, 75, 573 (1996)(4) Platenik, J., et al.: Life Sci., 67, 335 (2000)Formula:C14H15N3OColor and Shape:NeatMolecular weight:241.29
